Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Methods: Forty patients with recurrent ascites and cirrhosis were randomized 1:1 in a double blinded fashion to receive either dapagliflozin (10 mg/day) with standard medical therapy (Group A) or placebo with standard medical therapy (Group B)
Label every vial with the date, concentration, and contents
Serum metabolomics reveals irreversible Inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity
Our global team at REVIV brings together expertise from various fields to push the boundaries of nutritional science and genetics
Novel delivery systems, such as mifepristone-loaded nanostructured lipid carriers (NLCs), have been developed as an effective strategy for endometriosis-targeted therapy (136, 137)
Supporting diverse research areas
US$ 21.55
US$ 24.97
US$ 22.08
US$ 24.91
US$ 24.22
US$ 27.89
